Jennifer Michaelson
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
Jennifer Michaelson currently works at Cullinan Therapeutics, Inc., as Chief Scientific Officer from 2023.
Dr. Michaelson also formerly worked at Jounce Therapeutics, Inc., as Director-Tumor Immunology, Cullinan Oncology LLC, as Chief Development Officer-Biologics from 2020 to 2022, and Celsius Therapeutics, Inc., as Head-Biologics in 2017.
Dr. Michaelson received her undergraduate degree from Princeton University and doctorate degree from Albert Einstein College of Medicine, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-05-2026 | 166.844 ( 0,27% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Corporate Officer/Principal | 01-12-2017 |
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-07-2017 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Cullinan Oncology, Inc.
Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau